Metabolism and Excretion of Exogenous Thyrotropin-Releasing Hormone in Humans

Abstract

A B S T R A C T To study the metabolism of thyrotropinreleasing hormone (TRH) in vivo, 400 Ag TRH was administered intravenously to eight normal male subjects. Multiple plasma and urine samples were obtained before and after TRH administration. Serum TSH concentrations increased after TRH administration in all subjects. Plasma TRH levels, measured by radioimmunoassay, were undetectable (< 0.4 ng/ml) before TRH administration. Plasma TRH concentrations averaged 33±7 ng/ml (mean +SEM) 2 min after TRH injection. Thereafter, they decreased rapidly so that the mean plasma TRH level was 2.9 ng/ml 20 min after TRH administration. The fall in plasma TRH levels was linear during this interval. Thereafter TRH levels declined more slowly. The mean half-life (ti) of TRH was 5.3±0.5 min. The mean distribution volume was 15.7 ±3.8 liters, an average of 16.5% of body weight in these subjects. In the urine, 5.5±0.9% of the administered TRH was recovered in the 3 h after TRH administration. Of the total urinary TRH recovered, 84.9% was excreted in the first 30 min. These results indicate that TRH is distributed in a large volume, that it is rapidly metabolized and that a significant quantity of administered TRH is excreted in the urine. INTRODUCTIONThe administration of thyrotropin-releasing hormone (TRH)' to normal subjects is followed by a prompt increase in serum thyrotropin (TSH) concentrations.

Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients

“…Thus, we evaluated TSH secretion in 52 patients after the exclusion of the above three patients. We evaluated the ΔTSH (peak TSH minus basal TSH) [17,21]. Basal PRL was also elevated in 14 of the patients performed TRH test, suggesting abnormal regulation through inhibition of the …”

Functional Characterization of 5-Oxoproline Transport via SLC16A1/MCT1

“…According to Takeda Pharmaceutical Company Ltd., thyrotropin-releasing hormone (TRH), 2 also known as protirelin, is a tripeptide that consists of 5-oxoproline, histidine, and proline, and it is used for medical treatment of spinocerebellar ataxia. Administration of TRH to normal subjects results in a prompt increase of serum thyrotropin concentration.…”

Novel Diketopiperazine Enhances Motor and Cognitive Recovery after Traumatic Brain Injury in Rats and Shows Neuroprotection In Vitro and In Vivo

“…Thyrotropin-releasing hormone is rapidly metabolized through the action of endopeptidases (Bassiri and Utiger, 1973;Metcalf, 1982). Its metabolic product, the cyclic dipeptide cyclo(his-pro) (CHP) or histidyl-proline diketopiperazine, has considerable physiologic activity, as do other naturally occurring diketopiperazines (Prasad, 1995).…”